de Citadel Advisors Encompass Health EHC Historial de posiciones en acciones
Compró
Mantenido
Vendió
| Trimestre | Valor de mercado | Estado | Núm. de acciones |
Cambio en la participación | Valor operado | Peso en el portafolio | Posición de la cartera | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | USD 259 M | Comprar |
2,563,104
+2,051,217
| +401% | +USD 212 M | 0.03% | 435 |
|
|
2026
Q1 | USD 49.5 M | Comprar |
511,887
+394,416
| +336% | +USD 40.4 M | 0.01% | 1369 |
|
|
2025
Q4 | USD 12.5 M | Vender |
117,471
-194,183
| -62% | -USD 22.5 M | ﹤0.01% | 2960 |
|
|
2025
Q3 | USD 39.6 M | Vender |
311,654
-668,742
| -68% | -USD 79.6 M | 0.01% | 1615 |
|
|
2025
Q2 | USD 120 M | Comprar |
980,396
+40,341
| +4% | +USD 4.61 M | 0.02% | 650 |
|
|
2025
Q1 | USD 95.2 M | Comprar |
940,055
+506,139
| +117% | +USD 49.4 M | 0.02% | 728 |
|
|
2024
Q4 | USD 40.1 M | Vender |
433,916
-341,339
| -44% | -USD 33.5 M | 0.01% | 1474 |
|
|
2024
Q3 | USD 74.9 M | Vender |
775,255
-761,162
| -50% | -USD 68.4 M | 0.01% | 912 |
|
|
2024
Q2 | USD 132 M | Comprar |
1,536,417
+672,404
| +78% | +USD 56.4 M | 0.03% | 534 |
|
|
2024
Q1 | USD 71.4 M | Comprar |
864,013
+286,230
| +50% | +USD 21 M | 0.01% | 951 |
|
|
2023
Q4 | USD 38.5 M | Vender |
577,783
-1,292,946
| -69% | -USD 83.7 M | 0.01% | 1388 |
|
|
2023
Q3 | USD 126 M | Comprar |
1,870,729
+862,748
| +86% | +USD 59.3 M | 0.03% | 511 |
|
|
2023
Q2 | USD 68.3 M | Vender |
1,007,981
-114,111
| -10% | -USD 7.15 M | 0.01% | 825 |
|
|
2023
Q1 | USD 60.7 M | Vender |
1,122,092
-361,328
| -24% | -USD 21 M | 0.01% | 927 |
|
|
2022
Q4 | USD 88.7 M | Comprar |
1,483,420
+468,326
| +46% | +USD 25.5 M | 0.02% | 712 |
|
|
2022
Q3 | USD 45.9 M | Comprar |
1,015,094
+1,008,964
| +16,459% | +USD 50.5 M | 0.01% | 1140 |
|
|
2022
Q2 | USD 274 k | Vender |
6,130
-86,507
| -93% | -USD 4.44 M | ﹤0.01% | 9994 |
|
|
2022
Q1 | USD 5.24 M | Vender |
92,637
-103,111
| -53% | -USD 5.38 M | ﹤0.01% | 4081 |
|
|
2021
Q4 | USD 10.2 M | Vender |
195,748
-111,973
| -36% | -USD 5.78 M | ﹤0.01% | 3050 |
|
|
2021
Q3 | USD 18.4 M | Vender |
307,721
-1,182,420
| -79% | -USD 74.4 M | ﹤0.01% | 2127 |
|
|
2021
Q2 | USD 92.5 M | Comprar |
1,490,141
+103,204
| +7% | +USD 6.88 M | 0.02% | 717 |
|
|
2021
Q1 | USD 90.4 M | Comprar |
1,386,937
+869,690
| +168% | +USD 56.7 M | 0.02% | 636 |
|
|
2020
Q4 | USD 34 M | Vender |
517,247
-556,147
| -52% | -USD 32.7 M | 0.01% | 1278 |
|
|
2020
Q3 | USD 55.5 M | Comprar |
1,073,394
+829,810
| +341% | +USD 42.6 M | 0.02% | 790 |
|
|
2020
Q2 | USD 12 M | Vender |
243,584
-1,256,948
| -84% | -USD 67.8 M | ﹤0.01% | 2019 |
|
|
2020
Q1 | USD 76.4 M | Comprar |
1,500,532
+711,081
| +90% | +USD 41 M | 0.03% | 448 |
|
|
2019
Q4 | USD 43.5 M | Vender |
789,451
-212,849
| -21% | -USD 11.6 M | 0.02% | 859 |
|
|
2019
Q3 | USD 50.5 M | Comprar |
1,002,300
+78,757
| +9% | +USD 3.96 M | 0.02% | 757 |
|
|
2019
Q2 | USD 46.6 M | Comprar |
923,543
+355,487
| +63% | +USD 17.3 M | 0.02% | 767 |
|
|
2019
Q1 | USD 26.4 M | Vender |
568,056
-39,597
| -7% | -USD 2.01 M | 0.01% | 1108 |
|
|
2018
Q4 | USD 29.8 M | Comprar |
607,653
+506,970
| +504% | +USD 28.8 M | 0.02% | 928 |
|
|
2018
Q3 | USD 6.24 M | Comprar |
100,683
+92,372
| +1,111% | +USD 5.62 M | ﹤0.01% | 2703 |
|
|
2018
Q2 | USD 448 k | Vender |
8,311
-885
| -10% | -USD 44.2 k | ﹤0.01% | 6551 |
|
|
2018
Q1 | USD 418 k | Vender |
9,196
-209,821
| -96% | -USD 8.99 M | ﹤0.01% | 6206 |
|
|
2017
Q4 | USD 8.61 M | Vender |
219,017
-90,730
| -29% | -USD 3.45 M | 0.01% | 1880 |
|
|
2017
Q3 | USD 11.4 M | Comprar |
309,747
+108,567
| +54% | +USD 3.87 M | 0.01% | 1489 |
|
|
2017
Q2 | USD 7.75 M | Comprar |
201,180
+88,208
| +78% | +USD 3.23 M | 0.01% | 1677 |
|
|
2017
Q1 | USD 3.85 M | Comprar |
112,972
+66,795
| +145% | +USD 2.19 M | ﹤0.01% | 2310 |
|
|
2016
Q4 | USD 1.52 M | Comprar |
46,177
+27,513
| +147% | +USD 893 k | ﹤0.01% | 3294 |
|
|
2016
Q3 | USD 602 k | Comprar |
18,664
+7,609
| +69% | +USD 247 k | ﹤0.01% | 4568 |
|
|
2016
Q2 | USD 341 k | Comprar |
11,055
+837
| +8% | +USD 26.2 k | ﹤0.01% | 5032 |
|
|
2016
Q1 | USD 306 k | Vender |
10,218
-23,887
| -70% | -USD 660 k | ﹤0.01% | 5073 |
|
|
2015
Q4 | USD 945 k | Comprar |
34,105
+32,799
| +2,511% | +USD 933 k | ﹤0.01% | 3650 |
|
|
2015
Q3 | USD 40 k | Vender |
1,306
-69,919
| -98% | -USD 2.43 M | ﹤0.01% | 7729 |
|
|
2015
Q2 | USD 2.61 M | Comprar |
71,225
+66,042
| +1,274% | +USD 2.35 M | ﹤0.01% | 2752 |
|
|
2015
Q1 | USD 183 k | Vender |
5,183
-92,256
| -95% | -USD 3.16 M | ﹤0.01% | 6281 |
|
|
2014
Q4 | USD 2.98 M | Vender |
97,439
-449,501
| -82% | -USD 14 M | ﹤0.01% | 2486 |
|
|
2014
Q3 | USD 16.1 M | Comprar |
+546,940
| Nuevas | +USD 16.7 M | 0.02% | 1042 |
|
|
2014
Q2 | – | Vender |
-59,657
| Cerradas | -USD 1.7 M | – | 8026 |
|
|
2014
Q1 | USD 1.7 M | Vender |
59,657
-1,109
| -2% | -USD 28.9 k | ﹤0.01% | 2821 |
|
|
2013
Q4 | USD 1.61 M | Comprar |
+60,766
| Nuevas | +USD 1.69 M | ﹤0.01% | 2757 |
|
|
2013
Q3 | – | Vender |
-3,716
| Cerradas | -USD 85 k | – | 6762 |
|
|
2013
Q2 | USD 85 k | Comprar |
+3,716
| Nuevas | +USD 84 k | ﹤0.01% | 5333 |
|
Otros fondos que tienen EHC en su cartera
Posición de Citadel Advisors en EHC: resumen de T2 2026
Citadel Advisors aumentó su participación en Encompass Health (EHC) en 401% durante T2 2026, al comprar aproximadamente USD 212 M y elevar la posición a 2,563,104 acciones con un valor de USD 259 M. La posición representa 0.03% de la cartera y ocupa el puesto #435.
Citadel Advisors reportó por primera vez una posición en EHC en T2 2013 y la ha mantenido durante 51 trimestres desde entonces. Al cierre de T2 2026, 601 fondos que sigue Wall St. Rank mantienen una posición en EHC.
- Al cierre de T2 2026, Citadel Advisors tenía 2,563,104 acciones de Encompass Health con un valor de USD 259 M.
- Citadel Advisors compró 2,051,217 acciones de Encompass Health en T2 2026, por un monto estimado de USD 212 M.
- Encompass Health representó 0.03% de la cartera de Citadel Advisors en T2 2026 y fue su posición número 435.
- Citadel Advisors reportó por primera vez una posición en Encompass Health en T2 2013 y la ha mantenido durante 51 trimestres desde entonces.
- Al cierre de T2 2026, 601 fondos que sigue Wall St. Rank tenían Encompass Health en cartera.
Según el Informe 13F de Citadel Advisors correspondiente a T2 2026, presentado el 14 ago 2026.